Soo C. Lee

Soo C. Lee

110 Sengkang East Way
Sengkang New Town, 544886, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 128 publications

MyGeneRisk Colon: A Web-Based Tool for Personalized Colorectal Cancer Risk Prediction Based on Genetics and Lifestyle.

MyGeneRisk Colon: A Web-Based Tool for Personalized Colorectal Cancer Risk Prediction Based on Genetics and Lifestyle.

Journal: medRxiv : the preprint server for health sciences
Published: April 20, 2026

Decentralised germline genetic testing for epithelial ovarian cancer in a tertiary Asian centre.

Decentralised germline genetic testing for epithelial ovarian cancer in a tertiary Asian centre.

Journal: Annals of the Academy of Medicine, Singapore
Published: April 13, 2026

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology
Published: February 10, 2026

Health care policies, drug costs, and time toxicities in biologics for HER2-positive breast cancer: cost minimization analysis of direct and indirect costs.

Health care policies, drug costs, and time toxicities in biologics for HER2-positive breast cancer: cost minimization analysis of direct and indirect costs.

Journal: ESMO real world data and digital oncology
Published: February 06, 2026

Exploration of Real-World Data Sources in Latin America, Middle East and North Africa, and Asia Pacific, to Support Oncology Evidence Generation: A Targeted Literature Review and Regional Recommendations.

Exploration of Real-World Data Sources in Latin America, Middle East and North Africa, and Asia Pacific, to Support Oncology Evidence Generation: A Targeted Literature Review and Regional Recommendations.

Journal: Advances in therapy
Published: November 24, 2025

Toward Sustainable Care in HER2-Positive Metastatic Breast Cancer: Emerging Evidence for Treatment De-escalation.

Toward Sustainable Care in HER2-Positive Metastatic Breast Cancer: Emerging Evidence for Treatment De-escalation.

Journal: Cancer research and treatment
Published: October 16, 2025

Spectral computed tomography (CT) in breast lesion evaluation: clinical utility and imaging spectrum-a pictorial review.

Spectral computed tomography (CT) in breast lesion evaluation: clinical utility and imaging spectrum-a pictorial review.

Journal: Clinical radiology
Published: September 03, 2025

Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study.

Pembrolizumab monotherapy for previously treated metastatic HER2-negative breast cancer with germline APOBEC3B deletion: results of the phase II AUROR study.

Journal: The Lancet regional health. Western Pacific
Published: March 20, 2025

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.

Journal: JAMA
Published: January 30, 2025

Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination.

Cancer type and gene signatures associated with breakthrough infections following COVID-19 mRNA vaccination.

Journal: NPJ vaccines
Published: November 18, 2024

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies.

NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies.

Journal: Therapeutic advances in medical oncology
Published: November 07, 2024

Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing.

Pathogenic germline variants in cancer predisposition genes in patients with multiple primary cancers in an Asian population and the role of extended panel genetic testing.

Journal: ESMO open
Published: November 03, 2024
Showing 1-12 of 128

Last Updated: 09/26/2026